PhRMA’s prayer is answered
Executive Summary
Generic Pharmaceutical Association urges Pharmaceutical Research & Manufacturers of America to discontinue ad campaign entitled "Pray For A Miracle." Ad "shamelessly exploits the photograph of a critically ill child" and "serves no purpose in advancing the debate regarding Hatch/Waxman," GPhA says in Sept. 20 letter to PhRMA. Ad ran in the Washington Post Sept. 18...
You may also be interested in...
The best advertising is free
PhRMA defends "Pray for a Miracle" ad campaign in response to Sept. 20 letter from Generic Pharmaceutical Association (1"The Pink Sheet" Sept. 23, In Brief). "The ad accurately points out that the legislation you champion would reduce incentives for the discovery of new medicine," PhRMA President Alan Holmer told GPhA in a Sept. 24 letter. "Generic drugs will offer nothing to those patients whose chances for a cure would decline if that legislation were to pass"...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.